Skip to main content
Clinical Trials/NCT02990689
NCT02990689
Completed
Not Applicable

Clinical Study to Evaluate the Visual Performance of Three Multifocal IOLs

Carl Zeiss Meditec AG0 sites55 target enrollmentMarch 2012
ConditionsVisual Acuity

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Visual Acuity
Sponsor
Carl Zeiss Meditec AG
Enrollment
55
Primary Endpoint
Intermediate visual acuity
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The purpose of this study is to compare the performances of 2 bifocal IOLs and 1 trifocal IOL for far, near and intermediate vision.

Registry
clinicaltrials.gov
Start Date
March 2012
End Date
October 2015
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients of any gender, aged 50 to 80 years
  • Signed informed consent form
  • Healthy eyes besides cataract
  • Assured follow-up examinations
  • Stable corneal conditions within the last 12 months
  • Corneal astigmatism less than 1D
  • Implantation into the capsular bag by injector

Exclusion Criteria

  • Degenerative visual disorders (e.g. macular degeneration, optic nerve atrophy, or retinal disorders)
  • Pseudophakia
  • Cornea guttata; keratoplasty
  • Irregular astigmatism (e.g. Keratoconus)
  • Corneal scarring
  • Diabetic retinopathy
  • Amblyopia
  • Amotio operation; anamnesis with vitreous surgery
  • Pseudoexfoliation Syndrome; Uveitis
  • Previous intraocular and corneal surgery

Outcomes

Primary Outcomes

Intermediate visual acuity

Time Frame: 12 months

Secondary Outcomes

  • Distance visual acuity(12 months)
  • Near visual acuity(12 months)

Similar Trials